Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers ; volume:12 ; number:1 ; day:5 ; month:10 ; year:2012 ; pages:1-6 ; date:12.2012
BMC cancer ; 12, Heft 1 (5.10.2012), 1-6, 12.2012
- Urheber
-
Bjørnslett, Merete
- Beteiligte Personen und Organisationen
-
Knappskog, Stian
Lønning, Per Eystein
Dørum, Anne
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-12-454
- URN
-
urn:nbn:de:1111-201603045855
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bjørnslett, Merete
- Knappskog, Stian
- Lønning, Per Eystein
- Dørum, Anne
- SpringerLink (Online service)
Ähnliche Objekte (12)
Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers
MDM2 negatively regulates the human telomerase RNA gene promoter
Transactivation of the estrogen receptor promoter by BRCA1
Cisplatin in breast cancer treatment in BRCA1 carriers
Folic acid and cancer risk in BRCA1 carriers
Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent
SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
Identification of functional DNA variants in the constitutive promoter region of MDM2
GSTT2 promoter polymorphisms and colorectal cancer risk
Survival in Norwegian BRCA1 mutation carriers with breast cancer
Selenium and the risk of cancer in BRCA1 carriers
Pregnancy after breast cancer in BRCA1/2 mutation carriers
Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers
MDM2 negatively regulates the human telomerase RNA gene promoter
Transactivation of the estrogen receptor promoter by BRCA1
Cisplatin in breast cancer treatment in BRCA1 carriers
Folic acid and cancer risk in BRCA1 carriers
Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent
SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
Identification of functional DNA variants in the constitutive promoter region of MDM2
GSTT2 promoter polymorphisms and colorectal cancer risk
Survival in Norwegian BRCA1 mutation carriers with breast cancer
Selenium and the risk of cancer in BRCA1 carriers
Pregnancy after breast cancer in BRCA1/2 mutation carriers
Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers
MDM2 negatively regulates the human telomerase RNA gene promoter
Transactivation of the estrogen receptor promoter by BRCA1
Cisplatin in breast cancer treatment in BRCA1 carriers
Folic acid and cancer risk in BRCA1 carriers
Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent
SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
Identification of functional DNA variants in the constitutive promoter region of MDM2
GSTT2 promoter polymorphisms and colorectal cancer risk
Survival in Norwegian BRCA1 mutation carriers with breast cancer
Selenium and the risk of cancer in BRCA1 carriers